.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AX05_Glucosamine.Glucosamine .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AX05_Glucosamine.Glucosamine| name: | Glucosamine |
| ATC code: | M01AX05 | route: | oral |
| n-compartments | 1 |
Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. It is most commonly used as a dietary supplement for the treatment and management of osteoarthritis and joint pain. Glucosamine is not officially approved by the FDA for prescription use and is widely available as an over-the-counter supplement.
Pharmacokinetic parameters were reported for healthy adult volunteers (both male and female), following single oral administration of glucosamine sulfate. Parameters were typically derived from single-dose administration studies in healthy adults aged between 18 and 60 years.
Barclay, TS, et al., & McCart, GM (1998). Glucosamine. The Annals of pharmacotherapy 32(5) 574–579. DOI:10.1345/aph.17235 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9606479
Johnsen, M, et al., & Müller, RU (2016). Oral Supplementation of Glucosamine Fails to Alleviate Acute Kidney Injury in Renal Ischemia-Reperfusion Damage. PloS one 11(8) e0161315–None. DOI:10.1371/journal.pone.0161315 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27557097
Agiba, AM, et al., & Geneidi, AS (2018). Geriatric-Oriented High Dose Nutraceutical ODTs: Formulation and Physicomechanical Characterization. Current drug delivery 15(2) 267–277. DOI:10.2174/1567201814666170320143824 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28322163